Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. PURPOSE: To investigate whether there are differences between nondihydropyridine calcium channel blockers and beta blockers on heart rate in patients with paroxysmal and persistent atrial fibrillation (AF). METHODS: In present analysis of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Koldenhof, T, Van Gelder, I C, Crijns, H J G M, Rienstra, M, Tieleman, R G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
10.4.2 - Rate Control
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207001/
http://dx.doi.org/10.1093/europace/euad122.073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207001/
http://dx.doi.org/10.1093/europace/euad122.073

Ejemplares similares